Skip to main content

Table 3 Correlations between TGF-β1 and other parameters

From: Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

 

CHC N = 36

FL N = 45

NASH N = 42

CRP

ND

TGF-β1

TGF-β1

  

r = 0.37

r = 0.29

  

P = 0.08

P = 0.055

ALT

TGF-β1

TGF-β1

TGF-β1

 

r = -0.02

r = -0.13

r = -0.34

 

P = 0.9

P = 0.38

P = 0.026

BMI

TGF-β1

TGF-β1

TGF-β1

 

rho = 0.13

rho = 0.18

rho = 0.09

 

P = 0.46

P = 0.22

P = 0.56

US score

ND

TGF-β1

TGF-β1

  

rho = -0.08

rho = 0.05

  

P = 0.57

P = 0.72

Fibrosis score

TGF-β1

ND

TGF-β1

 

rho = -0.09

 

rho = 0.05

 

P = 0.60

 

P = 0.75

Age

TGF-β1

TGF-β1

TGF-β1

 

r = -0.02

r = 0.02

r = -0.009

 

P = 0.9

P = 0.9

P = 0.9

  1. CHC, chronic hepatitis C; FL, fatty liver; NASH, non-alcoholic steatohepatitis; ALT, alanine aminotransferase; CRP, C reactive protein; TGF-β1, transforming growth factor beta1; BMI, body mass index; US score, hepatic steatosis score at ultrasound; r, Pearson's correlation coefficient and rho, Spearman's rank correlation coefficient, chosen according to the variable distribution (normal or not normal as well as being ordinals, respectively); ND, not determined.